We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
3101
Altimmune
ALT
$568M
$51K ﹤0.01%
3,550
+2,418
+214% +$39.1K
APRE icon
3102
Aprea Therapeutics
APRE
$8.42M
$51K ﹤0.01%
503
+320
+175% +$37.3K
BNO icon
3103
United States Brent Oil Fund
BNO
$780M
$51K ﹤0.01%
3,210
+1,198
+60% +$18.4K
ESCA icon
3104
Escalade
ESCA
$277M
$51K ﹤0.01%
2,449
-159
-6% -$3.44K
EWQ icon
3105
iShares MSCI France ETF
EWQ
$332M
$51K ﹤0.01%
1,450
-2,006
-58% -$68.6K
FRST icon
3106
Primis Financial Corp
FRST
$413M
$51K ﹤0.01%
3,478
+2,271
+188% +$31.2K
FVCB icon
3107
FVCBankcorp
FVCB
$340M
$51K ﹤0.01%
3,639
-3,042
-46% -$40.6K
GBIO
3108
DELISTED
Generation Bio
GBIO
$51K ﹤0.01%
178
+21
+13% +$6.72K
IBIO icon
3109
iBio
IBIO
$70.5M
$51K ﹤0.01%
66
-5
-7% -$4.36K
LAND
3110
Gladstone Land Corp
LAND
$357M
$51K ﹤0.01%
2,763
-164
-6% -$2.84K
MDGL icon
3111
Madrigal Pharmaceuticals
MDGL
$11.8B
$51K ﹤0.01%
438
+399
+1,023% +$46.5K
ORMP icon
3112
Oramed Pharmaceuticals
ORMP
$182M
$51K ﹤0.01%
5,013
+4,786
+2,108% +$39.3K
SCHB icon
3113
Schwab US Broad Market ETF
SCHB
$45.1B
$51K ﹤0.01%
3,144
-5,964
-65% -$94K
TRNS icon
3114
Transcat
TRNS
$873M
$51K ﹤0.01%
1,042
-2,139
-67% -$91.7K
VEL icon
3115
Velocity Financial
VEL
$714M
$51K ﹤0.01%
5,754
+3,783
+192% +$28.9K
ENZ
3116
DELISTED
Enzo Biochem, Inc.
ENZ
$51K ﹤0.01%
14,887
-11,625
-44% -$36.2K
KLDO
3117
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$51K ﹤0.01%
6,312
-3,759
-37% -$40.9K
TRIL
3118
DELISTED
Trillium Therapeutics Inc.
TRIL
$51K ﹤0.01%
+4,782
New +$59.1K
TPCO
3119
DELISTED
Tribune Publishing Company Common Stock
TPCO
$51K ﹤0.01%
2,819
-2,734
-49% -$44.2K
GABC icon
3120
German American Bancorp
GABC
$1.93B
$50K ﹤0.01%
1,076
-2,045
-66% -$80.5K
GDYN icon
3121
Grid Dynamics Holdings
GDYN
$621M
$50K ﹤0.01%
3,157
-2,559
-45% -$36.8K
HMC icon
3122
Honda
HMC
$40.7B
$50K ﹤0.01%
1,662
-238
-13% -$6.85K
HOFV
3123
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$50K ﹤0.01%
453
-547
-55% -$33.1K
NGD
3124
DELISTED
New Gold Inc
NGD
$50K ﹤0.01%
32,341
-41,398
-56% -$74.8K
NNBR icon
3125
NN Inc
NNBR
$322M
$50K ﹤0.01%
7,100
-10,044
-59% -$68.4K
123 124
125
126 127

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.